
Miura backs dental specialist Proclinic
Miura Private Equity has acquired Spanish dental specialist Proclinic.
The deal values the company at around €100m, according to press reports.
Miura will partner with the founding Raneda de la Hoz family, who will retain a minority stake in the company.
The GP plans to further boost the company's growth in Spain, bolster its international expansion (primarily in Italy and France), and build a dental platform across southern Europe.
Miura is investing via its third fund, which closed on its €330m hard-cap in January 2018. The fund invests in companies based in Iberia with sales of more than €25m and EBITDA of more than €3m.
Company
Founded in 1983, Proclinic produces and distributes laboratory consumables, equipment, implants and orthodontics for dental clinics.
The company also offers dental training programmes through partnerships with academies and universities across Spain.
Proclinic is headquartered in Zaragoza, with further offices in Barcelona and Madrid. Employing 300 staff, it generated revenues of €140m in 2020, of which 25% came from the international market. It generates EBITDA of around €14m, according to press reports.
People
Miura Private Equity – Luis Seguí (founding partner, CEO); Carlos Julià (partner).
Proclinic – Julián Raneda De la Hoz (partner).
Advisers
Equity – PwC (financial due diligence); KPMG (financial due diligence); Baker McKenzie (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater